Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Baylor Genetics | RCV001332657 | SCV001525037 | uncertain significance | Polycystic kidney disease, adult type | 2019-09-23 | criteria provided, single submitter | clinical testing | This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. |
Gene |
RCV001664833 | SCV001873693 | uncertain significance | not provided | 2021-08-10 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |
Fulgent Genetics, |
RCV001332657 | SCV002787178 | uncertain significance | Polycystic kidney disease, adult type | 2021-12-10 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004035744 | SCV005005281 | uncertain significance | Inborn genetic diseases | 2023-11-28 | criteria provided, single submitter | clinical testing | The c.7405C>T (p.R2469C) alteration is located in exon 18 (coding exon 18) of the PKD1 gene. This alteration results from a C to T substitution at nucleotide position 7405, causing the arginine (R) at amino acid position 2469 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |